Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice

Lack of fragile X mental retardation protein (FMRP) causes Fragile X Syndrome, the most common form of inherited mental retardation. FMRP is an RNA-binding protein and is a component of messenger ribonucleoprotein complexes, associated with brain polyribosomes, including dendritic polysomes. FMRP is therefore thought to be involved in translational control of specific mRNAs at synaptic sites. In mice lacking FMRP, protein synthesis-dependent synaptic plasticity is altered and structural malformations of dendritic protrusions occur. One hypothesized cause of the disease mechanism is based on exaggerated group I mGluR receptor activation. In this study, we examined the effect of the mGluR5 antagonist MPEP on Fragile X related behavior in Fmr1 KO mice. Our results demonstrate a clear defect in prepulse inhibition of startle in Fmr1 KO mice, that could be rescued by MPEP. Moreover, we show for the first time a structural rescue of Fragile X related protrusion morphology with two independent mGluR5 antagonists.

[1]  W. Greenough,et al.  Sequence of abnormal dendritic spine development in primary somatosensory cortex of a mouse model of the fragile X mental retardation syndrome , 2005, American journal of medical genetics. Part A.

[2]  N. Gekakis,et al.  Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice. , 2006, Human molecular genetics.

[3]  K. Marquis,et al.  Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dawley rats , 1999, Psychopharmacology.

[4]  G. Bassell,et al.  Localization of FMRP‐associated mRNA granules and requirement of microtubules for activity‐dependent trafficking in hippocampal neurons , 2005, Genes, brain, and behavior.

[5]  Mark F. Bear,et al.  Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Geyer,et al.  The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity , 2002, Neuropharmacology.

[7]  J. Darnell,et al.  Fragile X Mental Retardation Protein Targets G Quartet mRNAs Important for Neuronal Function , 2001, Cell.

[8]  I. Weiler,et al.  Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Jens-Uwe Peters,et al.  Fenobam: A Clinically Validated Nonbenzodiazepine Anxiolytic Is a Potent, Selective, and Noncompetitive mGlu5 Receptor Antagonist with Inverse Agonist Activity , 2005, Journal of Pharmacology and Experimental Therapeutics.

[10]  Mark F. Bear,et al.  Correction of Fragile X Syndrome in Mice , 2007, Neuron.

[11]  D. Nelson,et al.  The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo , 2006, Neurobiology of Disease.

[12]  Mark F. Bear,et al.  Internalization of ionotropic glutamate receptors in response to mGluR activation , 2001, Nature Neuroscience.

[13]  M. Tranfaglia,et al.  Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP , 2005, Neuropharmacology.

[14]  I. Weiler,et al.  Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Segal,et al.  FMRP involvement in formation of synapses among cultured hippocampal neurons. , 2000, Cerebral cortex.

[16]  D. Nelson,et al.  Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. , 2006, Human molecular genetics.

[17]  Raffaele Ferri,et al.  Audiogenic Seizures Susceptibility in Transgenic Mice with Fragile X Syndrome , 2000, Epilepsia.

[18]  Alcino J. Silva,et al.  Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice , 2004, Molecular Psychiatry.

[19]  S. Grant,et al.  A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability , 2007, Nature Neuroscience.

[20]  C I De Zeeuw,et al.  Monitoring kinetic and frequency-domain properties of eyelid responses in mice with magnetic distance measurement technique. , 2002, Journal of neurophysiology.

[21]  Karel Svoboda,et al.  Abnormal Development of Dendritic Spines inFMR1 Knock-Out Mice , 2001, The Journal of Neuroscience.

[22]  A. Faden,et al.  Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors , 2005, British journal of pharmacology.

[23]  I. Weiler,et al.  Local Protein Synthesis and Spine Morphogenesis: Fragile X Syndrome and Beyond , 2006, The Journal of Neuroscience.

[24]  I. Weiler,et al.  RNA Cargoes Associating with FMRP Reveal Deficits in Cellular Functioning in Fmr1 Null Mice , 2003, Neuron.

[25]  Christina Gross,et al.  Dysregulated Metabotropic Glutamate Receptor-Dependent Translation of AMPA Receptor and Postsynaptic Density-95 mRNAs at Synapses in a Mouse Model of Fragile X Syndrome , 2007, The Journal of Neuroscience.

[26]  Stephen T Warren,et al.  Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors , 2007, Proceedings of the National Academy of Sciences.

[27]  W. Greenough,et al.  From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome , 2005, Nature Reviews Neuroscience.

[28]  E. De Schutter,et al.  Deletion of FMR1 in Purkinje Cells Enhances Parallel Fiber LTD, Enlarges Spines, and Attenuates Cerebellar Eyelid Conditioning in Fragile X Syndrome , 2005, Neuron.

[29]  Mariette Schrier,et al.  Transport of Fragile X Mental Retardation Protein via Granules in Neurites of PC12 Cells , 2002, Molecular and Cellular Biology.

[30]  J. Darnell,et al.  FMRP RNA targets: identification and validation , 2005, Genes, brain, and behavior.

[31]  R. Carroll,et al.  Local functions for FMRP in axon growth cone motility and activity-dependent regulation of filopodia and spine synapses , 2006, Molecular and Cellular Neuroscience.

[32]  Yan Wang,et al.  Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome , 2005, Neuron.

[33]  I. Weiler,et al.  Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Popoli,et al.  Neuroprotective effects of the mGlu5R antagonist MPEP towards quinolinic acid‐induced striatal toxicity: involvement of pre‐ and post‐synaptic mechanisms and lack of direct NMDA blocking activity , 2004, Journal of neurochemistry.

[35]  Yasushi Miyashita,et al.  Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons , 2001, Nature Neuroscience.

[36]  W. Brown,et al.  Analysis of neocortex in three males with the fragile X syndrome. , 1991, American journal of medical genetics.

[37]  A. Ostareck-Lederer,et al.  Evidence that fragile X mental retardation protein is a negative regulator of translation. , 2001, Human molecular genetics.

[38]  M. Bear,et al.  Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. , 2000, Science.

[39]  S. Warren,et al.  The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Segal,et al.  Morphological analysis of dendritic spine development in primary cultures of hippocampal neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  Guy Nagels,et al.  Fmr1 knockout mice: A model to study fragile X mental retardation , 1994, Cell.

[42]  É. Khandjian,et al.  The fragile X syndrome: exploring its molecular basis and seeking a treatment , 2006, Expert Reviews in Molecular Medicine.

[43]  D. McIntosh,et al.  Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report. , 1999, American journal of medical genetics.

[44]  Liang Li,et al.  Metabotropic glutamate subtype 5 receptors modulate fear-conditioning induced enhancement of prepulse inhibition in rats , 2007, Neuropharmacology.

[45]  Y. Hiraoka,et al.  Cadherin activity is required for activity-induced spine remodeling , 2004, The Journal of cell biology.

[46]  Mark F Bear,et al.  The mGluR theory of fragile X mental retardation , 2004, Trends in Neurosciences.

[47]  I. Weiler,et al.  Synaptic regulation of protein synthesis and the fragile X protein , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Bellomo,et al.  Endogenous Activation of Group-I Metabotropic Glutamate Receptors Is Required for Differentiation and Survival of Cerebellar Purkinje Cells , 2001, The Journal of Neuroscience.

[49]  Yue Feng,et al.  Dynamic association of the fragile X mental retardation protein as a messenger ribonucleoprotein between microtubules and polyribosomes. , 2008, Molecular biology of the cell.

[50]  J. Darnell,et al.  The fragile X mental retardation protein, FMRP, recognizes G-quartets. , 2004, Mental retardation and developmental disabilities research reviews.